Dan Cowell

Dan has managed and co-founded a number of innovative and commercially successful biotech companies over the past 25+ years and has a proven track record delivering value to shareholders.

With a background in drug discovery, Dan has taken three research services companies from foundation to exit as both a co-founder and NED, taken a gene editing company from start-up to IPO as COO, and co-founded and managed a digital mental health diagnostics platform.  

In addition to his role at at Momentous Therapeutics Dan also serves as a Non-Executive Director (NED) of Sentinel Oncology and was one of its initial investors. He is active in the funding and mentoring of early-stage technology companies